Consistent with these predictions, our experimental findings demonstrate that IL-6 robustly upregulates the expression of FOXO3a, FOXO1, STING, and autophagy markers (P62, LC3-2B) across diverse NSCLC cell lines. Here, MAP1LC3A is linked to non-small cell lung carcinoma.